TerminatedPhase 2NCT01102140

The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study

Studying Tako-Tsubo cardiomyopathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Jennifer Cowger , MD, MS
Principal Investigator
Jennifer C Matthews, MD, MS
Univeristy of Michigan Health System
Intervention
POMx, pomegranate polyphenol extract(drug)
Enrollment
20 target
Eligibility
21 years · All sexes
Timeline
20102013

Study locations (2)

Collaborators

POM Wonderful LLC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01102140 on ClinicalTrials.gov

Other trials for Tako-Tsubo cardiomyopathy

Additional recruiting or active studies for the same condition.

See all trials for Tako-Tsubo cardiomyopathy

← Back to all trials